Literature DB >> 27272450

Transplants for MDS and quality-of-life. But whose quality-of-life?

R P Gale1, I Pusic2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27272450     DOI： 10.1038/bmt.2016.147

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  5 in total

1.  Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international collaborative decision analysis.

Authors:  John Koreth; Joseph Pidala; Waleska S Perez; H Joachim Deeg; Guillermo Garcia-Manero; Luca Malcovati; Mario Cazzola; Sophie Park; Raphael Itzykson; Lionel Ades; Pierre Fenaux; Martin Jadersten; Eva Hellstrom-Lindberg; Robert Peter Gale; C L Beach; Stephanie J Lee; Mary M Horowitz; Peter L Greenberg; Martin S Tallman; John F DiPersio; Donald Bunjes; Daniel J Weisdorf; Corey Cutler
Journal:  J Clin Oncol       Date:  2013-06-24       Impact factor: 44.544

2.  Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study.

Authors:  N A Christakis; E B Lamont
Journal:  BMJ       Date:  2000-02-19

3.  Does quality of life impact the decision to pursue stem cell transplantation for elderly patients with advanced MDS?

Authors:  A El-Jawahri; H T Kim; D P Steensma; A M Cronin; R M Stone; C D Watts; Y-B Chen; C S Cutler; R J Soiffer; G A Abel
Journal:  Bone Marrow Transplant       Date:  2016-03-21       Impact factor: 5.483

4.  A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome.

Authors:  Corey S Cutler; Stephanie J Lee; Peter Greenberg; H Joachim Deeg; Waleska S Pérez; Claudio Anasetti; Brian J Bolwell; Mitchell S Cairo; Robert Peter Gale; John P Klein; Hillard M Lazarus; Jane L Liesveld; Philip L McCarthy; Gustavo A Milone; J Douglas Rizzo; Kirk R Schultz; Michael E Trigg; Armand Keating; Daniel J Weisdorf; Joseph H Antin; Mary M Horowitz
Journal:  Blood       Date:  2004-03-23       Impact factor: 22.113

5.  Nationally representative trends and geographic variation in treatment of localized prostate cancer: the Urologic Diseases in America project.

Authors:  K C Cary; S Punnen; A Y Odisho; M S Litwin; C S Saigal; M R Cooperberg
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-02-10       Impact factor: 5.554
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.